Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: J Am Coll Clin Pharm. 2022 Aug 27;5(11):1161–1175. doi: 10.1002/jac5.1699

Table 2.

Key Resources for Evaluating Evidence of Pharmacogenetic Associations

Resource Key information to be gained by the individual
URL
PharmGKB  • Review annotated literature (e.g., prescribing information, drug label, international pharmacogenetics (pgx) guidelines, clinical and variants)
 • Review drug pathway
 • Download allele definition, allele functionality, frequency, diplotype-phenotype tables
https://www.pharmgkb.org/
CPIC  • Download CPIC guidelines and supplements
 • Obtain key updates on guidelines since publication
 • Clinical decision support resources
https://cpicpgx.org/
DPWG  • Download DPWG guidelines
 • Read background on enzymes
https://www.knmp.nl/patientenzorg/medicatiebewaking/farmacogenetica/pharmacogenetics-1/pharmacogenetics
Association for Molecular Pathology with College of American Pathologists  • Review published Guidelines on Genotyping Allele Selection for various pharmacogenes https://www.amp.org/clinical-practice/practice-guidelines/
PharmVar  • Review variants of genes; nomenclature, evidence level, clinical function
https://www.pharmvar.org/

PharmGKB: Pharmagogenomics Knowledege Base; CPIC: Clinical Pharmacogenetics Implementation Consortium; DPWG: Dutch Pharmacogenetics Working Group; PharmVar: Pharmacogene Variation